Possible Causes of Failing to Meet Primary Endpoints: A Systematic Review of Randomized Controlled Phase 3 Clinical Trials in Patients With Non–Small Cell Lung Cancer

被引：0
|
作者：
Mitsugu Ikeda
Tatsuya Ochibe
Masahiro Tohkin
机构：
[1] Nagoya City University,Department of Regulatory Science, Graduate School of Pharmaceutical Sciences
来源：
Therapeutic Innovation & Regulatory Science | 2019年 / 53卷
关键词：
phase 3 clinical trial; systematic review; non—small cell lung cancer; primary endpoint; success rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：324 / 331
页数：7
相关论文
共 50 条
  • [11] The role of maintenance therapy in the treatment of elderly non-small-cell lung cancer patients: a meta-analysis of randomized controlled trials
    Zhang, Liangzhe
    Gao, Shugeng
    He, Jie
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 3435 - 3440
  • [12] Sublobar resection versus lobectomy for stage IA non-small-cell lung cancer: A systematic review and meta-analysis of randomized controlled trials
    Meldola, Patrick F.
    Toth, Otavio A. S.
    Schnorrenberger, Erick
    Machado, Pablo G.
    Chiarelli, Gabriel F. C.
    Kracik, Jose L. S.
    de Carvalho, Caio C.
    Lobo, Matheus de M.
    Gross, Jefferson L.
    SURGICAL ONCOLOGY-OXFORD, 2023, 51
  • [13] Effect of Exercise Interventions on Quality of Life in Patients With Lung Cancer: A Systematic Review of Randomized Controlled Trials
    Ma, Rui-Chen
    Yin, Ying-Ying
    Liu, Xin
    Wang, Ya-Qing
    Xie, Jiao
    ONCOLOGY NURSING FORUM, 2020, 47 (03) : E58 - E72
  • [14] Effectiveness and safety of pembrolizumab for patients with advanced non-small cell lung cancer in real-world studies and randomized controlled trials: A systematic review and meta-analysis
    Yang, Beibei
    Wang, Bing
    Chen, Yongbang
    Wan, Ning
    Xie, Fei
    Yang, Ning
    Lu, Liqing
    Xiao, Weibin
    Yuan, Jin
    Li, Jian
    Xie, Bo
    Ji, Bo
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [15] Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials
    Zhao, Lingdi
    Li, Wei
    Zhang, Huiying
    Hou, Nan
    Guo, Lanwei
    Gao, Quanli
    ONCOTARGETS AND THERAPY, 2015, 8 : 2775 - 2781
  • [16] The effect of ginsenoside Rg3 combined with chemotherapy on immune function in non-small cell lung cancer A systematic review and meta-analysis of randomized controlled trials
    Gao, Song
    Fang, Cancan
    Wang, Tiancheng
    Lu, Wenjie
    Wang, Nan
    Sun, Lingfeng
    Fang, Wenyou
    Chen, Yang
    Hu, Rongfeng
    MEDICINE, 2023, 102 (14) : E33463
  • [17] A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
    Nieder, Carsten
    Pawinski, Adam
    Dalhaug, Astrid
    Andratschke, Nicolaus
    RADIATION ONCOLOGY, 2012, 7
  • [18] A review of clinical trials of cetuximab combined with radiotherapy for non-small cell lung cancer
    Carsten Nieder
    Adam Pawinski
    Astrid Dalhaug
    Nicolaus Andratschke
    Radiation Oncology, 7
  • [19] Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
    Zhao, Binghao
    Zhang, Wenxiong
    Yu, Dongliang
    Xu, Jianjun
    Wei, Yiping
    LUNG CANCER, 2018, 122 : 10 - 21
  • [20] Patients' preferences for chemotherapy in non-small-cell lung cancer: A systematic review
    Blinman, Prunella
    Alam, Mahmood
    Duric, Vlatka
    McLachlan, Sue-Anne
    Stockler, Martin R.
    LUNG CANCER, 2010, 69 (02) : 141 - 147
12345